Acute Myocardial Infarction
Conditions
Interventions
Experimental group:dexmedetomidine
Control group:none
Sponsors
The Second Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Age
65 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Patients with acute myocardial infarction (AMI) aged >=65 years; 2. Onset time <=24h; 3. Receive PCI treatment; 4. Sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Ventricular fibrillation, cardiogenic shock, Killip ?-IV; 2. Postoperative systolic blood pressure continued to 240ms or degree II-III atrioventricular block; 4. Severe postoperative dyspnea, blood oxygen saturation <92%; 5. Disturbance of consciousness or previous severe cerebrovascular disease; 6. Known severe liver and kidney dysfunction; 7. Known allergy to dexmedetomidine; 8. Pregnant and lactating patients; 9. Malignant tumor or expected survival <1 year; 10. The investigator judged that the subjects had poor compliance and could not complete the study as required; 11. Participate in other randomized controlled studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| delirium; | — |
Secondary
| Measure | Time frame |
|---|---|
| mortality;left ventricular ejection fraction; | — |
Countries
China
Contacts
Public ContactTan Jinfeng
The Second Affiliated Hospital of Harbin Medical University
Outcome results
None listed